These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9524774)
21. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Weimar IS; de Jong D; Muller EJ; Nakamura T; van Gorp JM; de Gast GC; Gerritsen WR Blood; 1997 Feb; 89(3):990-1000. PubMed ID: 9028331 [TBL] [Abstract][Full Text] [Related]
22. Molecular characteristics of HGF-SF and its role in cell motility and invasion. Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W EXS; 1993; 65():311-28. PubMed ID: 8380739 [TBL] [Abstract][Full Text] [Related]
23. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642 [TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma. Tolnay E; Kuhnen C; Wiethege T; König JE; Voss B; Müller KM J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834 [TBL] [Abstract][Full Text] [Related]
25. Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. Lindner G; Menrad A; Gherardi E; Merlino G; Welker P; Handjiski B; Roloff B; Paus R FASEB J; 2000 Feb; 14(2):319-32. PubMed ID: 10657988 [TBL] [Abstract][Full Text] [Related]
26. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Jiang WG; Grimshaw D; Martin TA; Davies G; Parr C; Watkins G; Lane J; Abounader R; Laterra J; Mansel RE Clin Cancer Res; 2003 Sep; 9(11):4274-81. PubMed ID: 14519655 [TBL] [Abstract][Full Text] [Related]
27. The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis. Cortner J; Vande Woude GF; Rong S EXS; 1995; 74():89-121. PubMed ID: 8527903 [TBL] [Abstract][Full Text] [Related]
28. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c. MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502 [TBL] [Abstract][Full Text] [Related]
29. Invasion of retinal pigment epithelial cells: N-cadherin, hepatocyte growth factor, and focal adhesion kinase. Van Aken EH; De Wever O; Van Hoorde L; Bruyneel E; De Laey JJ; Mareel MM Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):463-72. PubMed ID: 12556370 [TBL] [Abstract][Full Text] [Related]
30. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Beilmann M; Odenthal M; Jung W; Vande Woude GF; Dienes HP; Schirmacher P Blood; 1997 Dec; 90(11):4450-8. PubMed ID: 9373255 [TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors. Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434 [TBL] [Abstract][Full Text] [Related]
32. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). To CT; Tsao MS Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803 [TBL] [Abstract][Full Text] [Related]
33. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Cao B; Su Y; Oskarsson M; Zhao P; Kort EJ; Fisher RJ; Wang LM; Vande Woude GF Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7443-8. PubMed ID: 11416216 [TBL] [Abstract][Full Text] [Related]
34. Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization. Yerushalmi GM; Leibowitz-Amit R; Shaharabany M; Tsarfaty I Neoplasia; 2002; 4(6):510-22. PubMed ID: 12407445 [TBL] [Abstract][Full Text] [Related]
35. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Elliott BE; Hung WL; Boag AH; Tuck AB Can J Physiol Pharmacol; 2002 Feb; 80(2):91-102. PubMed ID: 11934261 [TBL] [Abstract][Full Text] [Related]
36. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. Gherardi E; Sharpe M; Lane K; Sirulnik A; Stoker M Symp Soc Exp Biol; 1993; 47():163-81. PubMed ID: 8165564 [TBL] [Abstract][Full Text] [Related]
37. Bronchioalveolar morphogenesis of human bronchial epithelial cells depending upon hepatocyte growth factor. Kato T; Oka K; Nakamura T; Ito A J Cell Mol Med; 2015 Dec; 19(12):2818-26. PubMed ID: 26416301 [TBL] [Abstract][Full Text] [Related]
38. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809 [TBL] [Abstract][Full Text] [Related]
39. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Wang X; Le P; Liang C; Chan J; Kiewlich D; Miller T; Harris D; Sun L; Rice A; Vasile S; Blake RA; Howlett AR; Patel N; McMahon G; Lipson KE Mol Cancer Ther; 2003 Nov; 2(11):1085-92. PubMed ID: 14617781 [TBL] [Abstract][Full Text] [Related]